| Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin S Dalva-Aydemir, R Bajpai, M Martinez, KUA Adekola, I Kandela, C Wei, ... Clinical Cancer Research 21 (5), 1161-1171, 2015 | 145 | 2015 |
| Investigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metformin KUA Adekola, S Dalva Aydemir, S Ma, Z Zhou, ST Rosen, M Shanmugam Leukemia & lymphoma 56 (2), 450-459, 2015 | 48 | 2015 |
| Expression and phosphorylation of the AS160_v2 splice variant supports GLUT4 activation and the Warburg effect in multiple myeloma JC Cheng, SK McBrayer, C Coarfa, S Dalva-Aydemir, PH Gunaratne, ... Cancer & metabolism 1, 1-8, 2013 | 24 | 2013 |
| Toward In Vitro Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735, an Aurora Kinase Inhibitor S Dalva-Aydemir, CB Akyerli, ŞK Yüksel, H Keskin, MC Yakıcıer OMICS: A Journal of Integrative Biology 23 (10), 486-495, 2019 | 5 | 2019 |
| Current applications of biotechnology K Gartland, MV Magni, P Gahan, Y Deeni Erciyes University, 2015 | 4 | 2015 |
| Significance of inhibitory maternal killer-cell immunoglobulin-like receptor (KIR) and fetal KIR ligand genotype combinations in placenta related obstetric complications G Orgul, K Dalva, S Dalva-Aydemir, RG Alniacik, HG Donmez, AN Cakar, ... Journal of Reproductive Immunology 148, 103425, 2021 | 3 | 2021 |
| Effect of CD34⁺ Total/Myeloid CD34⁺ Cell Progenitors and B-Lymphoid Progenitors Within the Bone Marrow Grafts on the Hematopoietic Recovery After Hematopoietic Stem Cell … K Dalva, S Haskologlu, S Dalva-Aydemir, MD Oz, A Ozturk, S Ipek, ... Experimental and Clinical Transplantation: Official Journal of the Middle …, 2022 | | 2022 |
| Targeting Glycolysis and Compensatory Mitochondrial Metabolism In An In Vivo Xenograft Model Of Multiple Myeloma With FDA Approved Ritonavir and Metformin S Dalva-Aydemir, KUA Adekola, J Koblinski, N Raje, ST Rosen, ... Blood 122 (21), 1922, 2013 | | 2013 |
| Identification of Rfp (TRIM27) as a novel regulator of AP-1 mediated transcription SD Aydemir | | 2011 |
| CUDC-101 S Dalva-Aydemir, CB Akyerli, SK Yuksel, H Keskin, MC Yakıcıer | | |
